⏳ Fetching live dividend data...
Home › Calculator › IKNA Dividend Calculator 2026
Ikena Oncology, Inc. · NASDAQ
Price: $17.16 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IKNA → $14016.65M in 10 years · $1,158,348,378.80/month
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open IKNA position with:
Real after-tax yield depends on where you live and how you hold IKNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 11.66% | 8.86% | $1,166 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 9.91% | 7.11% | $991 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.33% | 6.53% | $933 / yr |
| 🇬🇧 UK ISA | 0% | 11.66% | 8.86% | $1,166 / yr |
| 🇬🇧 UK Taxable | 8.75% | 10.64% | 7.84% | $1,064 / yr |
| 🇨🇦 TFSA | 0% | 11.66% | 8.86% | $1,166 / yr |
| 🇨🇦 CA Taxable | 25% | 8.75% | 5.95% | $875 / yr |
| 🇦🇺 Super (pension) | 15% | 9.91% | 7.11% | $991 / yr |
| 🇦🇺 AU Taxable | 30% | 8.16% | 5.36% | $816 / yr |
| 🇩🇪 DE Taxable | 26.375% | 8.58% | 5.78% | $858 / yr |
| 🇫🇷 FR Taxable | 30% | 8.16% | 5.36% | $816 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IKNA pays quarterly — 4 times per year. Next ex-div: TBD.
How IKNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IKNA sourced from FMP /financial-growth endpoint — real data, not estimates.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IKNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →